참고문헌
- Belogurov, G. A., M. N. Vassylyeva, A. Sevostyanova, J. R. Appleman, A. X. Xiang, R. Lira, S. E. Webber, S. Klyuyev, E. Nudler, I. Artsimovitch, and D. G. Vassylyev. 2009. Transcription inactivation through local refolding of the RNA polymerase structure. Nature 457: 332-335. https://doi.org/10.1038/nature07510
- Dawind, W. 2000. Biology and global distribution of myxobacteria in soil. FEMS Microbiol. Rev. 24: 403-427. https://doi.org/10.1111/j.1574-6976.2000.tb00548.x
- Garcia, R., K. Gerth, M. Stadler, I. J. Jr. Dogma, and R. Müller. 2010. Expanded phylogeny of myxobacteria and evidence for cultivation of the 'unculturables'. Mol. Phylogenet. Evol. 57: 878-887. https://doi.org/10.1016/j.ympev.2010.08.028
- Gerth, K., H. Irschik, H. Reichenbach, and W. Trowitzsch. 1980. Myxothiazol, an antibiotic from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties. J. Antibiot. 33: 1474-1479. https://doi.org/10.7164/antibiotics.33.1474
- Gerth, K., S. Pradella, O. Perlova, S. Beyer, and R. Müller. 2003. Myxobacteria: proficient producers of novel natural products with carious biological activities-past and future biotechnological aspects with the focus on the genus Sorangium. J. Biotechnol. 106: 233-253. https://doi.org/10.1016/j.jbiotec.2003.07.015
- Gerth, K., W. Trowitzsch, V. Wray, G. Hofle, H. Irschik, and H. Reichenbach. 1982. Pyrrolnitrin from Myxococcus fulvus (Myxobacterales). J. Antibiot. 35: 1101-1103. https://doi.org/10.7164/antibiotics.35.1101
- Hagen, D. C., A. P. Bretscher, and D. Kaiser. 1978. Synergism between morphogenetic mutants of Myxococcus xanthus. Dev. Biol. 64: 284-296. https://doi.org/10.1016/0012-1606(78)90079-9
- Huntley, S., Y. Zhang, A. Treuner-Lange, S. Kneip, C. W. Sensen, and L. Søgaard-Andersen. 2012. Complete genome sequence of the fruiting myxobacterium Corallococcus coralloides DSM 2259. J. Bacteriol. 194: 3012-3013. https://doi.org/10.1128/JB.00397-12
- Hyun, H., J. Chung, H. Lee, J. Youn, C. Lee, D. Kim, and K. Cho. 2009. Isolation of cellulose-degrading myxobacteria Sorangium cellulosum. Korean J. Microbiol. 45: 48-53.
- Irschik, H. and H. Reichenbach. 1985. The mechanism of action of myxovalargin A, a peptide antibiotic from Myxococcus fulvus. J. Antibiot. 38: 1237-1245. https://doi.org/10.7164/antibiotics.38.1237
- Irschik, H., K. Gerth, T. Kemmer, H. Steinmetz, and H. Reichenbach. 1983. The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties. J. Antibiot. 36: 6-12. https://doi.org/10.7164/antibiotics.36.6
- Irschik, H., R. Jansen, G. Höfle, K. Gerth, and H. Reichenbach. 1985. The corallopyronins, new inhibitors of bacterial RNA synthesis from myxobacteria. J. Antibiot. 38: 145-152. https://doi.org/10.7164/antibiotics.38.145
- Kim, Y. S., W. C. Bae, and S. J. Back. 2003. Bioactive substances from myxobacteria. Korean J. Microbiol. Biotechnol. 31: 1-12.
- Park, S., B. Lee, J. Kim, C. Lee, E. Jang, and K. Cho. 2004. Isolation and characterization of bacteriolytic wild myxobacteria. Korean J. Microbiol. Biotechnol. 32: 218-223.
- Reichenbach, H. 2005. Myxococcales. pp. 1059-1144. In Brenner, D. J., N. R. Krieg, J. T. Staley, and G. M. Garrity (ed.), Bergey's Manual of Systematic Bacteriology, 2nd ed. Bergey's Manual Trust, East Lansing, MI, USA.
- Reichenbach, H. and G. Hofle. 1999. Myxobacteria as producers of secondary metabolites. pp. 149-179. In Grabley S. and R. Thiericke (ed.), Drug Discovery from Nature, Springer Verlag, Berlin, Germany.
- Reichenbach, H. and M. Dworkin. 1992. The myxobacteria, pp. 3416-3487. In Balows, A., H. G. Trper, M. Dworkin, W. Harder, and K.-H. Schleifer (ed.), The Prokaryotes, 2nd ed., vol. IV, Springer Verlag, New York, USA.
- Thierbach, G. and H. Reichenbach. 1981. Myxothiazol, a new antibiotic interfering with respiration. Antimicrob. Agents Chemother. 19: 504-507. https://doi.org/10.1128/AAC.19.4.504
- Weissman, K. J. and R. Müller. 2009. A brief tour of myxobacterial secondary metabolism. Bioorg. Med. Chem. 17: 2121- 2136. https://doi.org/10.1016/j.bmc.2008.11.025
- Weissman, K. J. and R. Müller. 2010. Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat. Prod. Rep. 27: 1276-1295. https://doi.org/10.1039/c001260m
- Wenzel, S. C. and R. Muller. 2009. The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat. Prod. Rep. 26: 1385-1407. https://doi.org/10.1039/b817073h
피인용 문헌
- 점액세균 Myxococcus stipitatus KYC4013에 의한 생리활성물질 생산 vol.42, pp.4, 2013, https://doi.org/10.4014/kjmb.1403.03003
- Identification of the Phenalamide Biosynthetic Gene Cluster in Myxococcus stipitatus DSM 14675 vol.26, pp.9, 2013, https://doi.org/10.4014/jmb.1603.03023
- Myxococcus stipitatus DSM 14675의 melithiazol 생합성 유전자 분석 vol.44, pp.3, 2013, https://doi.org/10.4014/mbl.1606.06008
- Genetic and Functional Analyses of the DKxanthene Biosynthetic Gene Cluster from Myxococcus stipitatus DSM 14675 vol.28, pp.7, 2013, https://doi.org/10.4014/jmb.1802.02045
- Effects of Myxococcus fulvus KYC4048 Metabolites on Breast Cancer Cell Death vol.28, pp.5, 2013, https://doi.org/10.4014/jmb.1711.11003
- 점액세균의 이차대사산물 vol.54, pp.3, 2013, https://doi.org/10.7845/kjm.2018.8042
- Myxococcus stipitatus의 자실체 형성을 위한 배지 조성 vol.55, pp.2, 2013, https://doi.org/10.7845/kjm.2019.9035
- Mutants defective in the production of encapsulin show a tan-phase-locked phenotype in Myxococcus xanthus vol.57, pp.9, 2019, https://doi.org/10.1007/s12275-019-8683-9
- Screening of Myxobacteria Carrying Tubulysin Biosynthetic Genes vol.49, pp.1, 2013, https://doi.org/10.48022/mbl.2010.10001
- The σ54 system directly regulates bacterial natural product genes vol.11, pp.1, 2013, https://doi.org/10.1038/s41598-021-84057-4